JW THERIAC Trademark

Trademark Overview

On Monday, November 3, 2025, a trademark application was filed for JW THERIAC with the United States Patent and Trademark Office. The USPTO has given the JW THERIAC trademark a serial number of 99476760. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, March 17, 2026. This trademark is owned by JW Holdings Corporation. The JW THERIAC trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Business consulting, management, and planning services in the field of genetics, bioengineering, microbiology, chemistry and pharmaceuticals; Business consulting and business information for enterprises; Business consulting and information services

Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Pharmaceutical products development; Pharmaceutical research and development; Consulting services in the field of pharmaceutical research and development; Pharmaceutical product evaluation; Consultancy pertaining to pharmacology; Research and development in the field of medical products and pharmaceuticals; Medical research
jw theriac

General Information

Serial Number99476760
Word MarkJW THERIAC
Filing DateMonday, November 3, 2025
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, March 17, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBusiness consulting, management, and planning services in the field of genetics, bioengineering, microbiology, chemistry and pharmaceuticals; Business consulting and business information for enterprises; Business consulting and information services
NOT AVAILABLE"THERIAC"
Goods and ServicesResearch and development of pharmaceuticals for the treatment of age-related diseases and cancer; Pharmaceutical products development; Pharmaceutical research and development; Consulting services in the field of pharmaceutical research and development; Pharmaceutical product evaluation; Consultancy pertaining to pharmacology; Research and development in the field of medical products and pharmaceuticals; Medical research

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, November 3, 2025
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 3, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJW Holdings Corporation
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGyeonggi-do 13840
KR

Trademark Events

Event DateEvent Description
Monday, November 3, 2025NEW APPLICATION ENTERED
Monday, November 3, 2025APPLICATION FILING RECEIPT MAILED
Thursday, November 6, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 17, 2026ASSIGNED TO EXAMINER
Tuesday, March 17, 2026SUSPENSION LETTER WRITTEN
Tuesday, March 17, 2026LETTER OF SUSPENSION E-MAILED
Tuesday, March 17, 2026NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Related Keywords

theriac development research pharmaceutical business consulting field pharmaceuticals services products information